Perma Plasindo Tbk vs Merck Tbk. — how do they compare? Perma Plasindo Tbk trades at Rp96 (market cap 216.16B, 50.3K 24h volume), while Merck Tbk. trades at Rp3,740 (market cap 1.68T, 22.8K 24h volume). The key difference: Merck Tbk. is far larger — about 7.8× Perma Plasindo Tbk's market cap, and Perma Plasindo Tbk is more actively traded (50.3K versus 22.8K). Which is the better fit depends on your goals.
| BINO | MERK | |
|---|---|---|
Market Cap | 216.16B | 1.68T |
Volume | 50.3K | 22.8K |
Lot | 503 | 228 |
Turnover | 4.77M | 82.9M |
Average Price | 94.8 | 3,636.14 |
Value | 4.77M | 82.9M |
Indicative Equilibrium Price | 96 | 3,520 |
Indicative Equilibrium Volume | 1 | 60 |
Trailing returns across standard periods
Latest headlines on both assets
PT Perma Plasindo Tbk (“the Company”) was established in Jakarta based on Notarial Deed No. 26 by Winanto Wiryomartani, S.H., dated May 6, 1992. The Company begin their operation activities in 1992.
Read more on BINO →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →